Association of DR4 gene polymorphism in Chinese patients with gastroduodenal diseases

Medical Journal of Wuhan University

Volumn 28, Issue 1, 2007, Pages

  Guo, Lu ^a   Xia, Bing ^a   Song, Qi ^a   Li, Chun ^a  

^a WUHAN UNIVERSITY   (China)

Author keywords

DR4; Gastric cancer; Gene polymorphism

Indexed keywords

EID: 33947407211     PISSN: 16718852     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Hengartner MO. The biochemistry of apoptosis[J]. Nature, 2000,407:770-776.
2. Evan GI, Vousden KH. Proliferation, cell cycle and apoptosis in cancer[J]. Nature, 2001,411:342-348.
3. Frank B, Hemminki K, Shanmugam KS, et al. Association of death receptor 4 haplotype 626C 683C with an increased breast cancer risk [J]. Carcinogenesis, 2005, 26(11):1 975-1 977.
4. Hazra A, Chamberlain RM, Grossman HB, et al. Death Receptor 4 and Bladder Cancer Risk [J]. Cancer Research, 2003,63:1 157-1 159.
5. Fisher MJ, Virmani AK, Wu L, et al. Nucleotide substitution in the ectodomain of trail receptor DR4 is associated with lung cancer and head and neck cancer[J]. Clin Cancer Res, 2001,7(6):1 698-1 697.
6. Kuraoka K, Matsumura S, Sanada Y. A single nucleotide polymorphism in the extracellular domain of TRAIL receptor DR4 at nucleotide 626 in gastric cancer patients in Japan[J]. Oncol Rep, 2005,14(2):465-470.
7. Bouralexis S, Findlay DM, Evdokiou A. Death to the bad guys: Targeting cancer via Apo2L/TRAIL [J]. Apoptosis, 2005,10:35-51.
8. Wolf S, Mertens D, Pscherer A, et al. Ala228 variant of trail receptor 1 affecting the ligand binding site is associated with chronic lymphocytic leukemia, mantle cell lymphoma, prostate cancer, head and neck squamous cell carcinoma and bladder cancer[J]. Int J Cancer, 2006,118(7):1 831-1 835.
9. Lee SH, Shin MS, Kim HS, et al. Somatic mutations of TRAIL-receptor 1 and TRAIL-receptor 2 genes in non-Hodgkin's lymphoma [J]. Oncogene, 2001,20 (3):399-403.
10. Shin EC, Ahn JM, Kim CH, et al. IFN-gamma induces cell death in human hepatoma cells through a TRAIL/death receptor-mediated apoptotic pathway [J]. Int J Cancer, 2001,93:262-268.